Living-Donor Liver Transplant Promising for CRC With Liver Mets
Recurrence-free survival of 62 percent, overall survival of 100 percent at 1.5 years after LDLT in select patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.